End Use - Hereditary Angioedema Therapeutics Market
The global end use hereditary angioedema therapeutics market size was valued at US$ 2,775.1 million in 2023 and is estimated to grow at a compound annual growth rate (CAGR) of 12.5% from 2023 to 2030.